Results 191 to 200 of about 2,173,693 (307)

A Framework for Assessing the Impact of Outbreak Response Immunization Programs. [PDF]

open access: yesDiseases
Delport D   +9 more
europepmc   +1 more source

Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs. [PDF]

open access: yesVaccine, 2022
Markowitz LE   +9 more
europepmc   +1 more source

N6‐Methyladenosine in Inflammatory Bowel Disease: An Emerging Regulator of Pathogenesis and a Novel Therapeutic Frontier

open access: yesiMetaMed, EarlyView.
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the intestine associated with an imbalance in intestinal homeostasis. m6A‐modifying enzymes, consisting of m6A writers, erasers and readers, plays a pivotal role in the pathogenesis and progression of IBD by affecting four intestinal barriers, including the intestinal mechanical ...
Jiaxian Guo   +4 more
wiley   +1 more source

Corrigendum: Rethinking immunization programs through the life course approach. [PDF]

open access: yesFront Public Health
Balsells E   +5 more
europepmc   +1 more source

Tofacitinib Regulates β‐Catenin Nuclear Translocation to Inhibit FLS Migration and Alleviate Clinical Symptoms of RA

open access: yesiNew Medicine, EarlyView.
ABSTRACT Objective Tofacitinib is a Janus kinase (JAK) inhibitor approved for the treatment of moderate‐to‐severe rheumatoid arthritis (RA). However, its synovium‐related molecular mechanisms, particularly its regulatory effect on fibroblast‐like synoviocyte (FLS) migration, remain incompletely understood.
Shuqi Fang   +13 more
wiley   +1 more source

Strengthening Capacity for Tailored Immunization Programs Using Adult Learning Principles: A Case Study from Nigeria. [PDF]

open access: yesGlob Health Sci Pract
Obi-Jeff C   +13 more
europepmc   +1 more source

Ethics check-up of public health immunization programs in Canada. [PDF]

open access: yesCan Commun Dis Rep, 2021
MacDonald NE, Harmon S, Graham JE.
europepmc   +1 more source

Preliminary Development and Assessment of a Multiplex Assay for Human Papillomavirus Antibody Detection Using Commercial L1 Proteins

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
This study developed and assessed a new multiplex assay for the simultaneous detection of antibodies against multiple Human Papillomavirus (HPV) types. Using recombinant L1 protein, the assay quantifies IgG and IgA responses in human plasma, enabling comprehensive immune profiling across multiple high‐risk cancer‐associated HPV genotypes. This approach
Arash Aslanabadi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy